Novavax shares fell 11.2% during Wednesday's session. Vaccine stocks are volatile after the first US bird flu death and a CDC ...

Novavax (NVAX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings ...

Novavax shares are trading higher by 12.4% during Tuesday's session. A recent CDC report highlights a sharp increase in ...

(NASDAQ:NVAX) shareholders might be concerned after seeing the share price drop 15% in the last quarter. But that scarcely detracts from the really solid long term returns generated by the company ...

Novavax Inc (NVAX) stock saw a modest uptick, ending the day at $10.82 which represents a slight increase of $1.06 or 10.86% from the prior close of $9.76. The stock opened at $9.95 and touched a low ...

Novavax (NVAX) and other vaccine developers rise as Investors react to rising flu and COVID-19 cases in the U.S. Read more ...

Shortly after President-elect Donald J. Trump nominated Robert F. Kennedy Jr. to lead the Department of Health and Human ...

The stock's fall snapped a five-day winning streak.

On Monday, Novavax Inc (NVAX) stock saw a decline, ending the day at $7.93 which represents a decrease of $-0.35 or -4.23% from the prior close of $8.28. The stock opened at $8.16 and touched a low of ...

Shares of Novavax Inc. NVAX shed 2.24% to $8.28 Friday, on what proved to be an all-around grim trading session for the stock ...

Novavax, Inc. (NASDAQ:NVAX – Get Free Report)’s share price traded down 5.8% during mid-day trading on Monday .The stock traded as low as $7.62 and last traded at $7.80. 1,894,875 shares ...

Novavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.